“Everything that Glows on PET is not Lymphoma”: An Unheralded Intruder in a Case of Diffuse Large B Cell Lymphoma
- 38 Downloads
Patients of diffuse large B cell lymphoma (DLBCL) with low (0–1) international prognostic score (IPI) has an expected 5 years survival of 73% . RCHOP remains the standard first line chemotherapy. Infections during and after chemotherapy is often encountered and more so in developing countries. However, isolated muscle cysticercosis is an unusual infection and moreover, FDG avid mass like presentation of cysticercosis is extremely rare. The index case was a prototype of low risk (IPI-0) DLBCL who responded and became asymptomatic with chemotherapy. However, an unexpected and unusual presentation of cysticercosis kept everybody guessing.
Compliance with Ethical Standards
Conflict of interest
There is no conflict of interest between the authors.
Informed signed written consent was taken from the patient involved.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Human and Animals Rights
No animals were involved in the study.